Xunbin Wei

Title: Xunbin Wei: Innovator in In-Vivo Monitoring Technologies

Introduction

Xunbin Wei is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of in-vivo monitoring of circulating apoptotic cells. With a total of 2 patents, his work has the potential to enhance cancer treatment monitoring.

Latest Patents

Xunbin Wei's latest patents focus on methods and systems for performing in vivo flow cytometry. In these inventions, selected circulating cells of interest in a subject are labeled with fluorescent probe molecules. The labeled cells are then irradiated in-vivo to excite the fluorescent probes. The emitted radiation from the excited probes is detected, preferably using confocal methods. This detected radiation is analyzed to derive important information, such as the relative cell count of the cells of interest. Notably, the circulating cells can include apoptotic cells, whose detection allows for non-invasive monitoring of the efficacy of cancer treatments, including anti-tumor and anti-angiogenic therapies.

Career Highlights

Throughout his career, Xunbin Wei has worked with prestigious organizations, including Massachusetts General Hospital Corporation and The General Hospital Corporation. His experience in these institutions has contributed to his expertise in medical innovations.

Collaborations

Xunbin Wei has collaborated with notable colleagues such as Charles P Lin and Dorothy Sipkins. These partnerships have likely enriched his research and development efforts in the field of in-vivo monitoring technologies.

Conclusion

Xunbin Wei's innovative work in the realm of in-vivo monitoring represents a significant advancement in medical technology. His patents and collaborations highlight his commitment to improving cancer treatment monitoring through cutting-edge methods.